These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of frozen plasma calibrants for enhanced standardization of the international normalized ratio (INR): a multi-center study. Adcock DM, Johnston M. Thromb Haemost; 2002 Jan; 87(1):74-9. PubMed ID: 11848460 [Abstract] [Full Text] [Related]
4. Standardization of prothrombin time for laboratory control of oral anticoagulant therapy. Kitchen S, Preston FE. Semin Thromb Hemost; 1999 Jan; 25(1):17-25. PubMed ID: 10327216 [Abstract] [Full Text] [Related]
5. Evaluation of international normalized ratios by a controlled field survey with 4 different thromboplastin reagents. Kazama M, Suzuki S, Abe T, Tahara C, Shimazu C, Akiyama Y, Higashi K, Ishiguro I, Kimura T, Motoi S. Thromb Haemost; 1990 Dec 28; 64(4):535-41. PubMed ID: 2084938 [Abstract] [Full Text] [Related]
6. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system. Testa S, Morstabilini G, Fattorini A, Galli L, Denti N, D'Angelo A. Haematologica; 2002 Dec 28; 87(12):1265-73. PubMed ID: 12495900 [Abstract] [Full Text] [Related]
8. [Control of oral anticoagulation. Current concepts]. Aguilar CA, Hurtado Monroy R, Gaspar Hernández J. Rev Invest Clin; 1989 Dec 28; 41(4):371-4. PubMed ID: 2698502 [Abstract] [Full Text] [Related]
9. Oral anticoagulant therapy control: evidence that INR expression improves the inter-laboratory comparability of results--the Bologna oral anticoagulant control exercise. Palareti G, Coccheri S, Poggi M, Bonetti M, Cervi V, Mazzuca A, Savoia M, Veri L, Fiori F, Gaspari G. Thromb Haemost; 1987 Oct 28; 58(3):905-10. PubMed ID: 3433253 [Abstract] [Full Text] [Related]
10. [Suggestions and propositions to resolve some issues for standardization of prothrombin time and activated partial thromboplastin time]. Kagawa K, Fukutake K. Rinsho Byori; 1999 May 28; 47(5):431-7. PubMed ID: 10375964 [Abstract] [Full Text] [Related]
11. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants. Horsti J. Haematologica; 2001 Aug 28; 86(8):851-5. PubMed ID: 11522542 [Abstract] [Full Text] [Related]
15. ISI/INR system in Japan: experience from simultaneous measurement of the same plasma at four different laboratories. Uetsuka Y, Sakuragawa N, Wada H, Aizawa Y, Aosaki M. Semin Thromb Hemost; 2000 Aug 28; 26(1):109-12. PubMed ID: 10805291 [Abstract] [Full Text] [Related]
16. Implications of use of low international sensitivity index thromboplastins in prothrombin time testing. Ts'ao C, Swedlund J, Neofotistos D. Arch Pathol Lab Med; 1994 Dec 28; 118(12):1183-7. PubMed ID: 7979911 [Abstract] [Full Text] [Related]
17. [Current biological surveillance of oral anticoagulant treatment]. Helft G, Vacheron A, Samama MM. Arch Mal Coeur Vaiss; 1995 Jan 28; 88(1):85-9. PubMed ID: 7646254 [Abstract] [Full Text] [Related]
19. Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins. Guglielmone HA, Vides MA. Ann Biol Clin (Paris); 1990 Jan 28; 48(8):547-50. PubMed ID: 2288441 [Abstract] [Full Text] [Related]
20. An International Sensitivity Index (ISI) derived from patients with abnormal liver function improves agreement between INRs determined with different reagents. Sermon AM, Smith JM, Maclean R, Kitchen S. Thromb Haemost; 2010 Apr 28; 103(4):757-65. PubMed ID: 20174759 [Abstract] [Full Text] [Related] Page: [Next] [New Search]